Log In
Print
BCIQ
Print
Print this Print this
 

UCB4940

  Manage Alerts
Collapse Summary General Information
Company UCB Group
DescriptionUndisclosed antibody-based product
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat immunological diseases
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today